Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 631

1.

A systematic review of simulation-based training tools for technical and non-technical skills in ophthalmology.

Lee R, Raison N, Lau WY, Aydin A, Dasgupta P, Ahmed K, Haldar S.

Eye (Lond). 2020 Mar 13. doi: 10.1038/s41433-020-0832-1. [Epub ahead of print] Review.

PMID:
32203241
2.

Percutaneous stenting of left hepatic vein followed by Ex vivo Liver Resection and Autotransplantation in a patient with hepatic alveolar echinococcosis with Budd-Chiari syndrome.

Zhang Y, Xie P, Yang C, Yang H, Liu J, Zhou G, Deng S, Lau WY.

Int J Surg Case Rep. 2020 Mar 9;68:251-256. doi: 10.1016/j.ijscr.2020.03.004. [Epub ahead of print]

3.

Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial.

Li J, Xing J, Yang Y, Liu J, Wang W, Xia Y, Yan Z, Wang K, Wu D, Wu L, Wan X, Yang T, Gao C, Si A, Wang H, Wu M, Lau WY, Chen Z, Shen F.

Lancet Gastroenterol Hepatol. 2020 Mar 9. pii: S2468-1253(19)30422-4. doi: 10.1016/S2468-1253(19)30422-4. [Epub ahead of print]

PMID:
32164877
4.

PSORTm: a bacterial and archaeal protein subcellular localization prediction tool for metagenomics data.

Peabody MA, Lau WYV, Hoad G, Jia B, Maguire F, Gray KL, Beiko RG, Brinkman FSL.

Bioinformatics. 2020 Feb 28. pii: btaa136. doi: 10.1093/bioinformatics/btaa136. [Epub ahead of print]

PMID:
32108861
5.

Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition).

Cheng S, Chen M, Cai J, Sun J, Guo R, Bi X, Lau WY, Wu M.

Liver Cancer. 2020 Jan;9(1):28-40. doi: 10.1159/000503685. Epub 2019 Nov 6. Review.

6.

A panel of five plasma proteins for the early diagnosis of hepatitis B virus-related hepatocellular carcinoma in individuals at risk.

Cheng K, Shi J, Liu Z, Jia Y, Qin Q, Zhang H, Wan S, Niu Z, Lu L, Sun J, Xue J, Lu C, Wei X, Guo L, Zhang F, Zhou D, Tang Y, Hu Y, Huang Y, Chen Y, Lau WY, Cheng S, Liu S.

EBioMedicine. 2020 Feb;52:102638. doi: 10.1016/j.ebiom.2020.102638. Epub 2020 Jan 31.

7.

Totally laparoscopic anatomic S7 segmentectomy using in situ split along the right intersectoral and intersegmental planes.

Cao J, Li WD, Zhou R, Shang CZ, Zhang L, Zhang HW, Lau WY, Chen YJ.

Surg Endosc. 2020 Jan 28. doi: 10.1007/s00464-020-07376-z. [Epub ahead of print]

PMID:
31993823
8.

Multicenter analysis of long-term oncologic outcomes of hepatectomy for elderly patients with hepatocellular carcinoma.

Xing H, Liang L, Wang H, Zhou YH, Pei YL, Li C, Zeng YY, Gu WM, Chen TH, Li J, Zhang YM, Wang MD, Zhang WG, Pawlik TM, Lau WY, Shen F, Wu MC, Yang T.

HPB (Oxford). 2020 Jan 21. pii: S1365-182X(19)33222-8. doi: 10.1016/j.hpb.2019.12.006. [Epub ahead of print]

PMID:
31980306
9.

Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis.

Xing H, Sun LY, Yan WT, Quan B, Liang L, Li C, Zhou YH, Wang H, Zhong JH, Gu WM, Chen TH, Wang MD, Wu H, Pawlik TM, Lau WY, Wu MC, Shen F, Yang T.

Surgery. 2019 Dec 23. pii: S0039-6060(19)30741-X. doi: 10.1016/j.surg.2019.11.005. [Epub ahead of print]

PMID:
31879090
10.

Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial.

Xia Y, Li J, Liu G, Wang K, Qian G, Lu Z, Yang T, Yan Z, Lei Z, Si A, Wan X, Zhang H, Gao C, Cheng Z, Pawlik TM, Wang H, Lau WY, Wu M, Shen F.

JAMA Oncol. 2019 Nov 27. doi: 10.1001/jamaoncol.2019.4477. [Epub ahead of print] Erratum in: JAMA Oncol. 2020 Jan 9;:.

PMID:
31774468
11.

The impact of portal vein tumor thrombus on long-term survival after liver resection for primary hepatic malignancy.

Zhang F, Lu CD, Zhang XP, Chen ZH, Zhong CQ, Hu YR, Wei XB, Zhou B, Wang K, Chai ZT, Wu MC, Lau WY, Cheng SQ.

HPB (Oxford). 2019 Nov 12. pii: S1365-182X(19)33181-8. doi: 10.1016/j.hpb.2019.10.2439. [Epub ahead of print]

PMID:
31732465
12.

A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B.

Yang T, Xing H, Wang G, Wang N, Liu M, Yan C, Li H, Wei L, Li S, Fan Z, Shi M, Chen W, Cai S, Pawlik TM, Soh A, Beshiri A, Lau WY, Wu M, Zheng Y, Shen F.

Clin Chem. 2019 Dec;65(12):1543-1553. doi: 10.1373/clinchem.2019.308965. Epub 2019 Oct 31.

PMID:
31672853
13.

Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study.

Xing H, Zhang WG, Cescon M, Liang L, Li C, Wang MD, Wu H, Lau WY, Zhou YH, Gu WM, Wang H, Chen TH, Zeng YY, Schwartz M, Pawlik TM, Serenari M, Shen F, Wu MC, Yang T.

HPB (Oxford). 2019 Oct 10. pii: S1365-182X(19)30718-X. doi: 10.1016/j.hpb.2019.09.006. [Epub ahead of print]

PMID:
31607637
14.

Real-world role of performance status in surgical resection for hepatocellular carcinoma: A multicenter study.

Wu H, Xing H, Liang L, Huang B, Li C, Lau WY, Zhou YH, Gu WM, Wang H, Chen TH, Zhang YM, Zeng YY, Pawlik TM, Wang MD, Wu MC, Shen F, Yang T.

Eur J Surg Oncol. 2019 Dec;45(12):2360-2368. doi: 10.1016/j.ejso.2019.09.009. Epub 2019 Sep 12.

PMID:
31543386
15.

Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.

Li C, Wang MD, Lu L, Wu H, Yu JJ, Zhang WG, Pawlik TM, Zhang YM, Zhou YH, Gu WM, Wang H, Chen TH, Han J, Xing H, Li ZL, Lau WY, Wu MC, Shen F, Yang T.

Hepatol Int. 2019 Nov;13(6):736-747. doi: 10.1007/s12072-019-09981-0. Epub 2019 Sep 5.

PMID:
31486964
16.

Association between body mass index and postoperative morbidity after liver resection of hepatocellular carcinoma: A multicenter study of 1,324 patients.

Yu JJ, Liang L, Lu L, Li C, Xing H, Zhang WG, Mao XH, Zeng YY, Chen TH, Zhou YH, Wang H, Pawlik TM, Wu H, Lau WY, Wu MC, Shen F, Yang T.

HPB (Oxford). 2020 Feb;22(2):289-297. doi: 10.1016/j.hpb.2019.06.021. Epub 2019 Aug 9.

PMID:
31405776
17.

Spontaneous rupture of hepatocellular carcinoma: Optimal timing of partial hepatectomy.

Wu JJ, Zhu P, Zhang ZG, Zhang BX, Shu C, Mba'nbo-Koumpa AA, Zhang ZW, Huang ZY, Zhang WG, Lau WY, Chen XP.

Eur J Surg Oncol. 2019 Oct;45(10):1887-1894. doi: 10.1016/j.ejso.2019.02.033. Epub 2019 Mar 5.

PMID:
31405632
18.

Impact of Surveillance in Chronic Hepatitis B Patients on Long-Term Outcomes After Curative Liver Resection for Hepatocellular Carcinoma.

Li ZL, Wu H, Wei YP, Zhong Q, Song JC, Yu JJ, Li C, Wang MD, Xu XF, Li JD, Han J, Xing H, Lau WY, Wu MC, Shen F, Yang T.

J Gastrointest Surg. 2019 Aug 6. doi: 10.1007/s11605-019-04295-w. [Epub ahead of print]

PMID:
31388886
19.

Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west.

Lu J, Zhang XP, Zhong BY, Lau WY, Madoff DC, Davidson JC, Qi X, Cheng SQ, Teng GJ.

Lancet Gastroenterol Hepatol. 2019 Sep;4(9):721-730. doi: 10.1016/S2468-1253(19)30178-5. Review.

PMID:
31387735
20.

Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.

Cai J, Chen L, Zhang Z, Zhang X, Lu X, Liu W, Shi G, Ge Y, Gao P, Yang Y, Ke A, Xiao L, Dong R, Zhu Y, Yang X, Wang J, Zhu T, Yang D, Huang X, Sui C, Qiu S, Shen F, Sun H, Zhou W, Zhou J, Nie J, Zeng C, Stroup EK, Zhang X, Chiu BC, Lau WY, He C, Wang H, Zhang W, Fan J.

Gut. 2019 Dec;68(12):2195-2205. doi: 10.1136/gutjnl-2019-318882. Epub 2019 Jul 29.

21.

Randomized Controlled Trial on Adjunctive Lavage for Severe Peritonitis.

Wong SS, Lau WY, Tse YY, Chan PK, Wan CK, Cheng YL, Yu AW.

Perit Dial Int. 2019 Sep-Oct;39(5):447-454. doi: 10.3747/pdi.2018.00111. Epub 2019 Jul 23.

PMID:
31337697
22.

Association of Preoperative Hypercoagulability with Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Liver Resection: A Multicenter Study.

Zhang XP, Zhou TF, Wang ZH, Zhang F, Zhong CQ, Hu YR, Wang K, Chai ZT, Chen ZH, Wu MC, Lau WY, Cheng SQ.

Ann Surg Oncol. 2019 Nov;26(12):4117-4125. doi: 10.1245/s10434-019-07504-7. Epub 2019 Jul 18.

PMID:
31321582
23.

Robotic vs laparoscopic hemihepatectomy: A comparative study from a single center.

Wang ZZ, Tang WB, Hu MG, Zhao ZM, Zhao GD, Li CG, Tan XL, Zhang X, Lau WY, Liu R.

J Surg Oncol. 2019 Sep;120(4):646-653. doi: 10.1002/jso.25640. Epub 2019 Jul 16.

PMID:
31313324
24.

Modifications of the AJCC 8th edition staging system for intrahepatic cholangiocarcinoma and proposal for a new staging system by incorporating serum tumor markers.

Cheng Z, Lei Z, Si A, Yang P, Luo T, Guo G, Zhou J, Wang X, Li Z, Xia Y, Li J, Wang K, Yan Z, Wei W, Hartmann D, Hüser N, Lau WY, Shen F.

HPB (Oxford). 2019 Dec;21(12):1656-1666. doi: 10.1016/j.hpb.2019.05.010. Epub 2019 Jul 13.

PMID:
31307889
25.

Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study.

Wei X, Jiang Y, Zhang X, Feng S, Zhou B, Ye X, Xing H, Xu Y, Shi J, Guo W, Zhou D, Zhang H, Sun H, Huang C, Lu C, Zheng Y, Meng Y, Huang B, Cong W, Lau WY, Cheng S.

J Clin Oncol. 2019 Aug 20;37(24):2141-2151. doi: 10.1200/JCO.18.02184. Epub 2019 Jul 8.

26.

Impact of postoperative infective complications on long-term survival after liver resection for hepatocellular carcinoma.

Yang T, Liu K, Liu CF, Zhong Q, Zhang J, Yu JJ, Liang L, Li C, Wang MD, Li ZL, Wu H, Xing H, Han J, Lau WY, Zeng YY, Zhou YH, Gu WM, Wang H, Chen TH, Zhang YM, Zhang WG, Pawlik TM, Wu MC, Shen F.

Br J Surg. 2019 Aug;106(9):1228-1236. doi: 10.1002/bjs.11231. Epub 2019 Jul 5.

PMID:
31276196
27.

Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.

Wang ZY, Tao QF, Wang ZH, Lin KY, Huang G, Yang Y, Zhou WP, Lau WY.

Am J Surg. 2019 Jun 13. pii: S0002-9610(18)31609-X. doi: 10.1016/j.amjsurg.2019.05.016. [Epub ahead of print]

PMID:
31266631
28.

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and its further developments in the last decade.

Lau WY.

Hepatobiliary Surg Nutr. 2019 Jun;8(3):258-259. doi: 10.21037/hbsn.2019.05.01. No abstract available.

29.

A Pretreatment CT Model Predicts Survival Following Chemolipiodolization in Patients With Hepatocellular Carcinoma.

Zhang Y, Qu S, Yi W, Zhai J, Zhang X, Wei L, Lau WY, Wu M, Shen F, Fan H, Wu D.

Technol Cancer Res Treat. 2019 Jan 1;18:1533033819844488. doi: 10.1177/1533033819844488.

30.

Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: An open-label randomized controlled trial.

Sun J, Yang L, Shi J, Liu C, Zhang X, Chai Z, Lau WY, Meng Y, Cheng SQ.

Radiother Oncol. 2019 Nov;140:20-25. doi: 10.1016/j.radonc.2019.05.006. Epub 2019 Jun 5.

PMID:
31176205
31.

Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma.

Tian MX, Liu WR, Wang H, Zhou YF, Jin L, Jiang XF, Tao CY, Tang Z, Zhou PY, Fang Y, Qu WF, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, Lau WY, Fan J, Shi YH.

BMC Med. 2019 Jun 5;17(1):106. doi: 10.1186/s12916-019-1341-6.

32.

Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysis.

Zhang XP, Chai ZT, Gao YZ, Chen ZH, Wang K, Shi J, Guo WX, Zhou TF, Ding J, Cong WM, Xie D, Lau WY, Cheng SQ.

HPB (Oxford). 2019 Dec;21(12):1687-1696. doi: 10.1016/j.hpb.2019.04.014. Epub 2019 May 29.

PMID:
31153833
33.

Extra-Glissonian Approach for Laparoscopic Liver Right Anterior Sectionectomy.

Chen HW, Wang FJ, Li JY, Deng FW, Lai ECH, Lau WY.

JSLS. 2019 Apr-Jun;23(2). pii: e2019.00009. doi: 10.4293/JSLS.2019.00009.

34.

An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.

Zhang XP, Wang K, Wei XB, Li LQ, Sun HC, Wen TF, Chai ZT, Chen ZH, Shi J, Guo WX, Xie D, Cong WM, Wu MC, Lau WY, Cheng SQ.

Oncologist. 2019 Dec;24(12):e1476-e1488. doi: 10.1634/theoncologist.2018-0868. Epub 2019 May 28.

35.

Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.

Wang MD, Li C, Li J, Zhang WG, Jiang WQ, Yu JJ, Xing H, Wu H, Han J, Li ZL, Xu XF, Chen TH, Zhou YH, Gu WM, Wang H, Zeng YY, Zhang YM, Pawlik TM, Lau WY, Wu MC, Yang JM, Shen F, Yang T.

Oncologist. 2019 Aug;24(8):e730-e739. doi: 10.1634/theoncologist.2018-0898. Epub 2019 May 24.

36.

Robotic versus laparoscopic liver resection in complex cases of left lateral sectionectomy.

Hu M, Liu Y, Li C, Wang G, Yin Z, Lau WY, Liu R.

Int J Surg. 2019 Jul;67:54-60. doi: 10.1016/j.ijsu.2019.05.008. Epub 2019 May 20.

PMID:
31121328
37.

Association of family history with long-term prognosis in patients undergoing liver resection of HBV-related hepatocellular carcinoma.

Li ZL, Han J, Liu K, Xing H, Wu H, Lau WY, Pawlik TM, Li C, Wang MD, Yu JJ, Wu MC, Shen F, Yang T.

Hepatobiliary Surg Nutr. 2019 Apr;8(2):88-100. doi: 10.21037/hbsn.2018.11.20.

38.

Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus:a multicenter study.

Xiang X, Lau WY, Wu ZY, Zhao C, Ma YL, Xiang BD, Zhu JY, Zhong JH, Li LQ.

Eur J Surg Oncol. 2019 Aug;45(8):1460-1467. doi: 10.1016/j.ejso.2019.03.042. Epub 2019 Apr 12.

PMID:
31005471
39.

A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter study.

Zhang XP, Chen ZH, Zhou TF, Li LQ, Chen MS, Wen TF, Shi J, Guo WX, Wu MC, Lau WY, Cheng SQ; Chinese National Research Cooperative Group for Diagnosis and Treatment of Hepatocellular Carcinoma with Tumour Thrombus.

Eur J Surg Oncol. 2019 Sep;45(9):1644-1651. doi: 10.1016/j.ejso.2019.03.043. Epub 2019 Apr 3.

PMID:
30982657
40.

An end-to-end pancreatic anastomosis in robotic central pancreatectomy.

Wang ZZ, Zhao GD, Zhao ZM, Gao YX, Xu Y, Yin ZZ, Liu Q, Lau WY, Liu R.

World J Surg Oncol. 2019 Apr 13;17(1):67. doi: 10.1186/s12957-019-1609-5.

41.

Water intake after dehydration makes muscles more susceptible to cramp but electrolytes reverse that effect.

Lau WY, Kato H, Nosaka K.

BMJ Open Sport Exerc Med. 2019 Mar 5;5(1):e000478. doi: 10.1136/bmjsem-2018-000478. eCollection 2019. Erratum in: BMJ Open Sport Exerc Med. 2019 Apr 11;5(1):e000478corr1.

42.

Extended Experience in the Use of Antibiotic Lock for Eradication of Biofilm Bacteria on Tenckhoff Catheter.

Wong SS, Lau WY, Chan PK, Wan CK, Cheng YL.

Perit Dial Int. 2019 Mar-Apr;39(2):187-190. doi: 10.3747/pdi.2018.00098.

PMID:
30858288
43.

Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma.

Si A, Li J, Yang Z, Xia Y, Yang T, Lei Z, Cheng Z, Pawlik TM, Lau WY, Shen F.

Ann Surg Oncol. 2019 Jun;26(6):1841-1850. doi: 10.1245/s10434-019-07260-8. Epub 2019 Mar 6.

PMID:
30843164
44.

Hydrochloric acid enhanced radiofrequency ablation for treatment of large hepatocellular carcinoma in the caudate lobe: Report of three cases.

Deng HX, Huang JH, Lau WY, Ai F, Chen MS, Huang ZM, Zhang TQ, Zuo MX.

World J Clin Cases. 2019 Feb 26;7(4):508-515. doi: 10.12998/wjcc.v7.i4.508.

45.

Severe hemodynamic instability during elective surgery for a patient with a giant pheochromocytoma: A case report.

Hu JY, Wang C, Wang HB, Chen PX, Zhen ZJ, Lau WY.

Int J Surg Case Rep. 2019;56:59-62. doi: 10.1016/j.ijscr.2019.01.021. Epub 2019 Jan 30.

46.

Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis.

Zhang XP, Liu YC, Chen ZH, Sun JX, Wang K, Chai ZT, Shi J, Guo WX, Wu MC, Lau WY, Cheng SQ.

Ann Surg Oncol. 2019 May;26(5):1465-1473. doi: 10.1245/s10434-019-07223-z. Epub 2019 Feb 14.

PMID:
30767178
47.

Comment on "Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in Aninternational Cohort".

Yu J, Wang Z, Lau WY, Yang T.

Ann Surg. 2019 Mar;269(3):e34. doi: 10.1097/SLA.0000000000002870. No abstract available.

PMID:
30724807
48.

The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study.

Han J, Li ZL, Xing H, Wu H, Zhu P, Lau WY, Zhou YH, Gu WM, Wang H, Chen TH, Zeng YY, Wu MC, Shen F, Yang T.

HPB (Oxford). 2019 Aug;21(8):962-971. doi: 10.1016/j.hpb.2018.11.005. Epub 2019 Feb 2.

PMID:
30718183
49.

Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC.

Yang T, Hu LY, Li ZL, Liu K, Wu H, Xing H, Lau WY, Pawlik TM, Zeng YY, Zhou YH, Gu WM, Wang H, Chen TH, Han J, Li C, Wang MD, Wu MC, Shen F.

J Gastrointest Surg. 2020 Feb;24(2):320-329. doi: 10.1007/s11605-018-04071-2. Epub 2019 Jan 7.

PMID:
30617773
50.

Liver resection is justified for multinodular hepatocellular carcinoma in selected patients with cirrhosis: A multicenter analysis of 1,066 patients.

Li ZL, Yu JJ, Guo JW, Sui CJ, Dai BH, Zhang WG, Chen TH, Li C, Gu WM, Zhou YH, Wang H, Zhang YM, Mao XH, Pawlik TM, Wang MD, Liang L, Wu H, Lau WY, Wu MC, Shen F, Yang T.

Eur J Surg Oncol. 2019 May;45(5):800-807. doi: 10.1016/j.ejso.2018.12.016. Epub 2018 Dec 21.

PMID:
30594407

Supplemental Content

Loading ...
Support Center